Tarius SAC Tracker®
Results Wire: US FDA Advisory Committee Unanimously Supports Kythera’s Deoxycholic Acid Injection for Reducing Chin Fat and Earlier Development of Systemic Treatments for Resistant Atopic Dermatitis in Pediatric Patients – MAR 9, 2015 (DODAC)
The SAC Tracker report for this meeting is only available for SAC Tracker Premium subscribers.
The SAC Tracker reports are available for FREE on this site until 10 days after the meeting is held.
To obtain unlimited access to SAC Tracker meeting reports back to 2010 and onwards, including the committee members' voting history, you must subscribe to the SAC Tracker Premium service.
METADATA: Sponsor: Kythera Biopharmaceuticals Drug Name: deoxycholic acid Drug Class: cytolytic Indication: reduction in chin fat, atopic dermatitis